GP 127 (Metformin 850 mg)
Pill imprint GP 127 has been identified as Metformin hydrochloride 850 mg.
Metformin is used in the treatment of diabetes, type 2; polycystic ovary syndrome; female infertility; insulin resistance syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 850 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GP 127 (Metformin 850 mg)
- 850 mg
- 13.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|67544-1383||Prepak Systems Inc (repackager)|
Note: Inactive ingredients may vary.
Metformin hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...